Navigation Links
Cervarix, GSK Cervical Cancer Candidate Vaccine, Demonstrates 100,Percent Protection Against Precancerous Lesions Caused By,Cancer-Causing Human Papillomavirus Types 16 & 18 for More Than,Five Years

evaluations were performed. Women were referred for colposcopy following protocol guidelines. Women were also assessed for long-term immunogenicity and safety.

About cervical cancer and its progression

Approximately 100 types of human papillomavirus have been identified to date and, of these, approximately 15 virus types are considered to cause cervical cancer. Virus types 16, 18, 45 and 31 are responsible for approximately 80 percent of cervical cancers globally. Persistent infection with a cancer-causing virus type leads to the formation of abnormal cells in the cervix, which, over time, may become precancerous or cancerous. Throughout their lifetime, women may be exposed to cancer-causing virus types and are potentially at risk of developing cervical cancer.

Globally, cervical cancer is the second leading cause of cancer death among women 20-39 years of age after breast cancer.

The GSK Cervical Cancer Candidate Vaccine Around the World

In addition to the Biologics License Application submitted for CERVARIX(R) with the U.S. Food and Drug Administration, GSK has submitted a marketing authorization application to the European Medicines Agency, Australia, Canada, and major countries in Asia and Latin America.

About GlaxoSmithKline

GlaxoSmithKline-one of the world's leading research-based pharmaceutical and healthcare companies-is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For company information, please visit www.gsk.com/media.

GSK Biologicals (GSK Bio), one of the world's leading vaccine manufacturers, is headquartered in Rixensart, Belgium, where the majority of GlaxoSmithKline's activities in the field of vaccine research, development and production are conducted. GSK Bio employs more than 1,500 scientists, who are devoted to discovering new vaccines and developing more cost-effective and
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Cervarix, the GSK Cervical Cancer Candidate Vaccine, Provides Sustained Immune Response in 100 Percent of Women up to 55 Years of Age
2. Vaccine Can Prevent Cervical Cancer and Precancerous Lesions
3. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
4. New England Journal of Medicine Publishes New Data on Gardasil, Mercks Cervical Cancer Vaccine
5. Nventa Announces Presentation of Positive HspE7 Data from NCI-Sponsored Clinical Trial in Cervical Dysplasia
6. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
7. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
8. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
9. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
Post Your Comments:
(Date:12/15/2009)... YORK, Dec. 15 Reportlinker.com ... report is available in its catalogue: ... strategic assessment of the competitive environment ... priority management responsibilities, the task crucial ... Timely and factual competitive intelligence is ...
(Date:12/15/2009)... YORK, Dec. 15 Reportlinker.com ... report is available in its catalogue: ... Therapeutics - Market Forecasts to 2015, ... Analysis ,, http://www.reportlinker.com/p0168102/The-Future-of-HIV-Therapeutics---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html ... author has released its latest research ...
(Date:12/15/2009)... 15 NxStage Medical, Inc. (Nasdaq: ... products, today announced that a group of its ... embarking on a week-long, conventional (non-dialysis) Caribbean cruise ... cruise, dubbed the "2010 Freedom Cruise: We,re Taking ... on January 3, 2010 and returns on January ...
Breaking Medicine Technology:Reportlinker Adds Top Ten World's Leading Orthopedics Companies 2Reportlinker Adds Top Ten World's Leading Orthopedics Companies 3Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 2Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 3Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 4Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 5Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 6Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 7Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 8Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 9Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 10Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 11Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 12Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 2Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 3Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 4Photo 3A Moms To Be Can Eat Well Even on a Budget 57785 1Photo 3A Moms To Be Can Eat Well Even on a Budget 57785 2Photo 3A Moms To Be Can Eat Well Even on a Budget 57785 3Photo 3A Moms To Be Can Eat Well Even on a Budget 57785 4Photo 3A Moms To Be Can Eat Well Even on a Budget 57785 5Clean Hands Report Card 28R 29 3A Americans Get a B on Hand Hygiene 57783 1Clean Hands Report Card 28R 29 3A Americans Get a B on Hand Hygiene 57783 2Clean Hands Report Card 28R 29 3A Americans Get a B on Hand Hygiene 57783 3A Dementia That Afflicts Younger Population Has Similarities to Alzheimers Applicable Treatments 57781 1A Dementia That Afflicts Younger Population Has Similarities to Alzheimers Applicable Treatments 57781 2A Dementia That Afflicts Younger Population Has Similarities to Alzheimers Applicable Treatments 57781 3A Dementia That Afflicts Younger Population Has Similarities to Alzheimers Applicable Treatments 57781 4
... Pre-mixed insulin,analogues, a modified form of conventional pre-mixed ... controlling high blood sugar,levels after meals in patients ... by the Agency for Healthcare Research and Quality, ... Services., Conventional pre-mixed human insulin, however, appears ...
... 15 The National,Alliance for Thrombosis and ... Steven K. Galson, MD, MPH for issuing ... deep vein thrombosis (DVT) and pulmonary,embolism (PE)., ... morning in Washington DC,( http://www.surgeongeneral.gov/topics/deepvein/calltoaction/call-to-action -,on-dvt-2008.pdf ). ...
Other Medicine Technology:Modified Insulin Most Effective For Controlling Post-Meal Blood Sugar Levels 2Modified Insulin Most Effective For Controlling Post-Meal Blood Sugar Levels 3Surgeon General's 'Call to Action' to Prevent DVT/PE Praised by NATT as Turning Point 2
(Date:12/15/2009)... 15 The new compact LifeSpan TR200 folding ... www.LifeSpanFitness.com ), was highly praised by treadmill review ... 2010. The compact TR200 folding treadmill received awards for ... under $1000. ,, The compact LifeSpan TR200 treadmill ... workout spaces. "This category buster is a very compact ...
(Date:12/15/2009)... service, such as tutoring children, can help older ... to a study led by researchers at the ... functional magnetic resonance imaging (fMRI), the researchers found ... made gains in key brain regions that support ... daily life. The study is the first of ...
(Date:12/15/2009)... new employment opportunity for the unemployed or those needing additional income... ... America today. , ... Orlando, FL (PRWEB) December 15, ... agencies, is spreading holiday cheer and good will that is going ... created an opportunity for out of work Americans to get back ...
(Date:12/15/2009)... Dec. 15 Accelify is proud to announce ... of Advisors. David will serve as Director of Development ... Accelify,s National Board of Advisors. ,, David ... District,s Board of Education in June 1995. As the ... of over 600,000 stretching from Northeast Los Angeles through ...
(Date:12/15/2009)... NEW YORK, Dec. 15 ... research report is available in its ... Cardiovascular Diseases Therapeutics - Market Forecasts ... and Deals Analysis ,, ... ,, The author has released its ...
Breaking Medicine News(10 mins):Health News:Treadmill Reviews Rate Compact LifeSpan Treadmill Best Treadmill 2Health News:For older adults, participating in social service activities can improve brain functions 2Health News:RPS Worldwide Launches Affiliate Program -- The Collection Agency That Gives Christmas Back, Rather Than Take it Away 2Health News:RPS Worldwide Launches Affiliate Program -- The Collection Agency That Gives Christmas Back, Rather Than Take it Away 3Health News:Accelify Announces the Addition of David Tokofsky to its National Board of Advisors 2Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 2Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 3Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 4Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 5Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 6Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 7Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 8Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 9Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 10Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 11Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 12Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 13Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 14Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 15Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 16Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 17
... Vice President Ann Converso, RN, to Serve as President, ... today announced the death of President Cheryl L. Johnson,RN. ... System on,Friday, Oct. 19, with a ruptured brain aneurysm ... family and friends., "Cheryl was a guiding force ...
... Cystic Fibrosis,Foundation was selected today as the 2006 Charitable ... the national governing body of track and,field, long-distance running ... for its largest fundraising program --,GREAT STRIDES -- a ... for other road races, jogs and marathons that raise ...
... POINT, Calif., Oct. 29 Howard A.,McLure, President ... Caremark,was elected Chairman of the Pharmaceutical Care Management ... In addition to,becoming the new Board Chairman, Mr. ... Meeting, a two-day event which features health care ...
... are diagnosed with breast cancer at a younger age ... than Caucasian women, a Yale School of Medicine researcher ... Therapeutic Radiology and Oncology meeting in Los Angeles, ... Yale Cancer Center member, said her results were based ...
... 29, 2007 — For some epilepsy patients, the side ... seizures. One pressing concern is the cognitive impairment seizures ... and reduced attention spans. , Now scientists at Washington ... observed seizure-induced structural changes in brain cells in laboratory ...
... new research on the topics of cardiovascular risk ... injury, racial and ethnic disparities of kidney disease, ... presented during the American Society of Nephrology,s 40th ... at a policy-centered news briefing on Saturday, November ...
Other Medicine News:Health News:UAN Mourns Passing of President Cheryl L. Johnson, RN 2Health News:Cystic Fibrosis Foundation Named Charitable Organization of the Year by USA Track & Field 2Health News:CVS Caremark's Howard McLure Elected New PCMA Board Chairman 2Health News:Breast cancer is more aggressive in African-American women 2Health News:Epilepsy-induced brain cell damage prevented in the laboratory 2
Exceptional illumination and realiability from this small source....
Tested by surgeons for functionality and ergonomy. Uses the Medifix C3-3001-3CCD camera head....
Integrated electronics, single-chip CCD camera with PAL and NTSC output. PAL output at 460 lines, NTSC output at 470 lines, focal length 30mm. 90mm length x 20mm diameter....
Large-image field with titanium couplers for c-mount scopes. 30mm focal length....
Medicine Products: